Dosing & Administration Convenience Efficacy Previous Next Power meets Synergy Metabolic benefit in a combination therapy 17/08/2022 | Author: Boehringer Ingelheim KM1_EMEP-2022-CSF1_Benefit of empagliflozin in a combination therapy Document ID: PC-ZA-101708 Synjardy Efficacy product item Efficacy Metabolic benefit in a combination therapy Related content Watch now 4:24 A meta analysis on CRM outcome studies of SGLT2-I Watch now Download PDF Powerful Combination of Empagliflozin/Metformin Download Home Metabolic Metabolic benefit in a combination theraphy